Overview
Study information
| Network: | GHDC |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase II |
| Species: | Human |
| Stage: | In progress |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A randomized, placebo controlled, partially blinded Phase II study to evaluate safety, immunogenicity, and prevention of infection with Mycobacterium tuberculosis of AERAS-404 and BCG revaccination in healthy adolescents
Description
BCG TB case control (VS-ID36-Frahm) is an immune correlates analysis of BCG vaccinees enrolled in AERAS C-0040-404.
Sign in to see full information about this study and to download study data.
Products
BCG Saline H4 antigen IC31Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.